A Decade of Progress, A Future of Hope - A Report to the Nation

    TORONTO, Sept. 28 /CNW/ - New findings in the battle against a deadly
disease will be discussed by scientists and survivors over the next three
days. The prostate cancer conference "A Decade of Progress, A Future of Hope"
will present a Report to the Nation on achievements made in understanding and
treating prostate cancer.
    Media are invited to attend presentations by keynote speakers at the
conference that will highlight the medical and scientific progress made in the
last decade since the first National Prostate Cancer Forum in 1997. The
conference will be held Friday September 28 through Sunday September 30 at The
Westin Harbour Castle, Harbour Ballroom and is hosted by the Canadian Prostate
Cancer Research Initiative (CPCRI) and the Canadian Prostate Cancer Network
(CPCN). For a listing of dates and times of keynote presentations please see
the attached agenda.
    The Canadian Cancer Statistics 2007 reports over 20,000 Canadian men will
be diagnosed with prostate cancer this year which translates into a tremendous
economic and social burden for those not only living with the disease but
their families and for all Canadians. By 2022 treatment costs for prostate
cancer are expected to peak at $286 million annually. Researchers will present
and discuss innovations in prostate cancer prevention, early detection,
treatment and survivorship which will contribute to reducing that burden.

    Prevention and Early Detection
    New evidence will be presented about the role that inflammation and
infection play in contributing to prostate cancer as well as the preventive
impact of diet and drug therapies such as Finasteride.
    Extensive progress has been made identifying new, disease-specific
genetic biomarkers for the detection of prostate cancer with the next step
being the clinical application of these markers for improved prostate cancer

    Major advancements in the treatment of prostate cancer will be reviewed,
including surgical and radiation techniques that result in shorter hospital
stays, reduced side effects and fewer complications. Now more than ever before
patients are also playing an active role in their treatment-decision making.
This shift combined with the major treatment advances achieved means the
quality of life for men living with prostate cancer is improving.

    "Understanding the toll prostate cancer takes on men living with the
disease is important in addressing how to improve their quality of life," says
Bob Shiell, President of the CPCN and Conference Co-host. Conference
participants will hear new and clear evidence about how physical activity
positively impacts men living with prostate cancer. These studies will help
men make better choices to optimize their overall health, but will especially
benefit men undergoing active treatment. Research into sexual health and
management of treatment related symptoms is also a focus of survivorship
issues that will be presented.

    The Canadian Prostate Cancer Research Initiative is a partnership of
organizations committed to reducing the incidence of, and mortality due to,
prostate cancer. Comprised of representatives from the National Cancer
Institute of Canada (NCIC), the Canadian Cancer Society (CCS), the Canadian
Prostate Cancer Network (CPCN) and the Canadian Institutes of Health Research
(CIHR), the Initiative is the only national funding organization that focuses
on research into all areas of prostate cancer from prevention to palliation,
and its goal is to reduce prostate cancer incidence and death.

    Media Backgrounder - Agenda of Keynote Presentations for Media

    Toronto: The following sessions of the prostate cancer conference "A
Decade of Progress, A Future of Hope" are open to media representatives. All
sessions will be held at the Westin Harbour Castle Hotel, 1 Harbour Square,
Toronto. On-site, speakers will be available for interviews following their
presentations. Requests for interviews should be coordinated through Robin
Reece, conference media communications consultant.

    Friday September 28th - 6:45pm to 9:15pm
    "A Decade of Progress: What Has Been Achieved Since the National Prostate
    Cancer Forum in 1997"
    Conference Chair: Dr. Michael Baker, Physician-in-Chief, University
    Health Network
    Professor of Medicine, University of Toronto

    "Innovations and Challenges in Prostate Cancer"
    Dr. Laurence Klotz, Chief, Division of Urology, Sunnybrook Health
    Sciences Centre, Toronto

    Saturday September 29th 8:00am - 10:00am
    "Early Detection of Prostate Cancer and its Challenges: A Rationale for
    Cancer Prevention"
    Dr. Ian Thompson, Chairman, Urology, The University of Texas Health
    Science Centre, San Antonio

    "Prevention of Prostate Cancer: Update 2007"
    Dr. Neil Fleshner, Head, Division of Urology, University Health Network

    Saturday September 29th 12:45pm - 1:30pm (concurrent sessions)
    "Surviving Prostate Cancer: New Evidence on How Exercise Can Help"
    Kerry Cournyea, PhD., Professor and Canada Research Chair in Physical
    Activity and Cancer, Faculty of Physical Education and Recreation,
    University of Alberta

    "Prostate Cancer Bio-Markers: Past, Present, Future"
    Dr. Robert Nam, Associate Scientist, Clinical Epidemiology, Sunnybrook
    Research Institute; Staff Physician, Sunnybrook Health Sciences Centre

    Saturday September 29th 8:00pm - 9:00pm
    "Progress in Prostate Cancer - CCS: Working With You and For You"
    Dr. Barbara Whylie, Chief Executive Officer, Canadian Cancer Society and
    National Cancer Institute of Canada

    "Let's Hear it For the Boys"
    Mr. Mark Dailey, Television Journalist, Co-Anchor of Toronto's "CityNews
    Tonight" and prostate cancer survivor

    Sunday September 30th 8:30am - 10:00am
    "Canadian Prostate Cancer BioResearch Network"
    Colleen Nelson, PhD
    Chair, CPCRI Management Committee
    Senior Scientist, The Prostate Centre at Vancouver General Hospital
    Associate Professor, Department of Surgery, University of British

    "FISH and CHIPs: Choosing the Best Prostate Cancer Therapy for Men Using
    Individual Tissue Signatures"
    Dr. Robert Bristow
    Clinician-Scientist, Princess Margaret Hospital, University Hospital
    Assistant Professor, Departments of Radiation Oncology and Medical
    Biophysics, University of Toronto

    Sunday September 30th 11:30am- 12:30
    "A Future of Hope"
    Conference Chair: Dr. Michael Baker, Physician-in-Chief, University
    Health Network
    Professor of Medicine, University of Toronto

For further information:

For further information: To set-up interviews, photo opportunities or
more information contact: Robin Reece, Media Communications Coordinator, (416)

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890